Tyrosine kinase inhibitors

Tyrosine kinase inhibitors
These can be divided into subclasses based on the targeted receptors, and associated symptoms are as follows:
 * Anaplastic lymphoma kinase
 * Seizures
 * BCR-ABL
 * Hemorrhages (subdural hematoma, IPH)
 * B rapidly accelerated fibrosarcoma inhibitor
 * Cerebral edema
 * Bruton tyrosine kinase
 * Hemorrhages (subdural hematoma, IPH)
 * VEGFR and others
 * Ischemic stroke
 * PRES
 * Hemorrhages (IPH, SAH)
 * Guillain-Barre and myasthenia gravis for sunitinib